Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Protagonist Therapeutics
Business Segments
Products & Services
Revenue
Revenue
Protagonist Therapeutics
·
Products & Services
·
1 segment
·
Rolls up to
Total Revenue
Breakdown
Segments
Fusfertide Clinical Trial Supplies
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q2 '26
Fusfertide Clinical Trial Supplies
$11M
Total
$213.48M
